Vivanza Biosciences Ltd Company Summary

Vivanza Biosciences Limited, formerly known as Ivee Injectaa Limited was established in March, 1982 as a Private Limited Company and was later on, converted into a Public Limited Company in May, 1992. Due to recessionary trends which lead to difficult business conditions in year 1999-2000, the parenteral industry suffered a setback and due to this, the name of the Company was changed from Ivee Injectaa Limited to Vivanza Biosciences Limited in 2015.The Company has a 40- years track record of innovation and success in developing oral drug delivery systems. These technologies have been commercialized in numerous products that are marketed around the world.

It has expertise in complex oral and topical dose forms including highly potent compounds, modified release products & injections. The Company is focused in commercializing novel and generic pharmaceutical medicines, offering patients better, safe and more accessible medicines. Head quartered in Gujarat, India, the Company came into existence in April 2016 to further spread its wings in global market with global quality pharmaceutical products at competitive pricing system.

Company undertook an expansion-cum-diversification programme to increase its capacity from 18 lac pa to 54 lac pa. The Company came out with a public issue of 21,70,000 equity shares of Rs 10 each for cash at par aggregating Rs 217 lac. It is one of the few companies which has facilities for both glass as well as plastic containers.

The Company acquired 100% Equity Shares of Vivanza Lifesciences Private Limited, making it a Wholly Owned Subsidiary w.e.f. 17 June, 2018.Since competition in the industry is continuously increasing. New technology is being adopted and steps are taken to improve the manufacturing capacity of the Company.

Further, the Company has also set its vision in global market to supply and execute turnkey pharmaceutical units.